WILLIAM GROSS - 15 Jun 2023 Form 4 Insider Report for Heliogen, Inc. (HLGN)

Role: 10%+ Owner
Signature: /s/ William Gross
Issuer symbol: HLGN
Transactions as of: 15 Jun 2023
Net transactions value: +$317,340
Form type: 4
Filing time: 16 Jun 2023, 16:30:14 UTC
Previous filing: 13 Jun 2023
Next filing: 23 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HLGN	Common Stock	Options Exercise	$317,340	+1,763,000	+66%	$0.1800	4,435,612	15 Jun 2023	Direct
holding	HLGN	Common Stock						414,363	15 Jun 2023	See footnote	F1
holding	HLGN	Common Stock						16,175	15 Jun 2023	See footnote	F2
holding	HLGN	Common Stock						15,480,443	15 Jun 2023	See footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HLGN	Employee Stock Option (right to buy)	Options Exercise	$0	-1,763,000	-67%	$0.000000	858,465	15 Jun 2023	Common Stock	1,763,000	$0.1800	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held by The Gross Goodstein Living Trust (the "Trust") of which Mr. Gross is a co-trustee. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2	These shares are held by Idealab Studio, LLC ("Idealab Studio"), for which Mr. Gross serves as chairman and chief executive officer. The Trust owns a majority of the class of securities of Idealab Studio entitled to elect two managers to Idealab Studio's board of managers. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3	These shares are held by Idealab Holdings, LLC ("Idealab Holdings"), which is a wholly owned subsidiary of Idealab, a California corporation ("Idealab"). Idealab is managed by a board of directors (the "Idealab Board") including Mr. Gross. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F4	The options vested and became exercisable in equal monthly installments commencing December 21, 2020, subject to Mr. Gross's continuous service which ceased effective February 5, 2023.
F5	The options were exercisable through the indicated expiration date pursuant to an extension granted by the Issuer. The original expiration date was approximately 10 years from the initial vesting date of options with the same exercise price.